Key committee meets Thursday to consider FDA authorization for Pfizer/BioNTech Covid-19 vaccine

There's not much suspense going into Thursday's meeting of the US Food and Drug Administration's vaccine advisers, who are discussing emergency use authoriza...

Posted: Dec 10, 2020 8:48 AM
Updated: Dec 10, 2020 9:30 AM

There's not much suspense going into Thursday's meeting of the US Food and Drug Administration's vaccine advisers, who are discussing emergency use authorization for Pfizer and BioNTech's coronavirus vaccine.

The EUA is widely expected and has been telegraphed with unusual frankness from the top of the FDA on down.

'Our team has done their initial analysis, and we do feel that preliminarily that the success criteria have been met,' FDA Commissioner Dr. Stephen Hahn told CNN Tuesday.

But the FDA has promised to listen to the advice of its Vaccines and Related Biological Products Advisory Committee, made up of independent vaccine experts, infectious disease specialists, industry representatives and a consumer representative -- 17 regular members and 13 temporary voting members. The meeting begins at 9 a.m. Thursday, and a committee vote could come in the afternoon.

The only real questions will be about whether the advisers recommend restrictions to the EUA -- perhaps leaving children off the lIst for now, for example. They'll also discuss how to conduct the post-EUA safety surveillance and whether to offer the shot to clinical trial volunteers who got placebo doses.

Unprecedented speed for vaccines

The US federal government is supporting the development of seven coronavirus vaccines -- four of them in large Phase 3 clinical trials. Two, made by Pfizer and Moderna, have now applied for EUAs.

All have been developed with unprecedented speed. The virus known as SARS-CoV-2 was only identified in January but just weeks after it was isolated, the Chinese government shared its genetic sequence and that was enough to get work started on vaccines.

Companies, academic researchers and the federal government had been working to develop so-called platforms that could be used to quickly turn around new vaccines. The first two to the finish line, Pfizer's and Moderna's, use a plug-and-play technology involving genetic material known as messenger RNA.

The approach had already been tried out against infectious diseases such as Zika and against cancer as well, so researchers were confident it was safe. It is also far faster than old-fashioned vaccine development techniques such as, for instance, influenza vaccines, which require samples of the actual virus which must be grown in specially chosen chicken eggs, purified and made into a vaccine -- an uncertain and slow process.

The mRNA vaccines need just a short stretch of genetic code and employ the human body itself to make its own vaccine. Tests in tens of thousands of volunteers starting in the summer showed it elicited an immune response and appeared to do so safely.

'We've shortened vaccine timelines here without compromising vaccine safety and efficacy,' Dr. Peter Marks, the head of the FDA's Center for Biologics Evaluation and Research, which approves vaccines, told an American Medical Association webinar.

'The fact that we have so many cases of Covid-19 right now, it's so unfortunate for us as a country. The only upside to it is when you are doing a clinical trial with an endpoint that's a clinical infectious disease endpoint, it's been easy to get to those endpoints because there's just so many cases,' Marks added.

'By August to October of this year it became clearer to us that the first vaccines that came through would indeed likely be granted emergency use authorization because of the incredibly pressing nature of this crisis.'

Getting 'down and dirty' with vaccine data

Pfizer's vaccine does have what researchers have described as breathtaking efficacy. The company released its first data in media releases, but turned over tens of thousands of pages of it data to the FDA for closer study.

Drug companies usually write up summaries of their findings for regulators, but the FDA also asks for all of the primary source material -- the charts, even each volunteer's individual record. Marks said staffers have studied that.

'We are the ones that actually don't just look at the companies' tables. We actually get down and dirty and we look at the actual adverse event reports, the bad spelling errors that are made by physicians sometimes, et cetera,' Marks said.

'They had 95% effectiveness across a wide range of individuals,' he told the AMA.

The FDA published its summary and Pfizer's summary on the Vaccines and Related Biological Products Advisory Committee website Tuesday, and the 95% efficacy claims hold up.

'Vaccine efficacy against confirmed COVID-19 occurring at least 7 days after Dose 2 was 94.6%, with 9 and 169 cases in the BNT162b2 (the vaccine's experimental name) and placebo groups respectively,' the FDA review document reads.

In other words, nine people who got the vaccine developed coronavirus infections with symptoms after the second shot, while 169 people who got placebo shots became infected.

The committee will run through all this data, but members will have read it all before Thursday's meeting, which will be livestreamed on YouTube, Twitter and the FDA's website.

How the meeting unfolds

Staff at the FDA's Office of Vaccines Research and Review will run down the FDA's study of Pfizer's data. Dr. Nancy Messonnier, who heads the US Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases, will review the CDC's plans for safety monitoring and other CDC officials will update on the pandemic itself and plans for distributing the vaccine.

Stanford University's Dr. Steven Goodman will talk about what it means for clinical trials going forward if a vaccine is approved. He'll address the question of asking people to forgo getting a vaccine known to be protective in order to test an unproven one.

Other possible questions are whether to include pregnant women and children in an EUA.

'At this point I would say, we may not have the data we need to actually be able to advise pregnant women, and we may need additional study,' Hahn said.

The committee members will almost certainly discuss allergy warnings out of Britain's vaccination campaign, as well.

And the National Vaccine Advisory Committee asked the FDA to leave children out of an EUA.

'The NVAC warns against issuing an Emergency Use Authorization (EUA) for COVID-19 vaccines in children, considering that children typically experience generally mild disease, except for multisystem inflammatory syndrome in children (MIS-C), a rare but serious condition that causes inflammation and various symptoms such as abdominal pain, vomiting, diarrhea, neck pain, rash, tiredness, and bloodshot eyes,' the group said last week.

Pfizer will also present its data.

Then the committee votes whether to recommend authorization.

But that doesn't mean the vaccine will be authorized immediately. The decision comes from the FDA, which typically follows the advisory committee's recommendation.

'One question that will come up is how fast will we see a vaccine authorized after that,' FDA's Marks told the AMA.

'It will depend on the discussion at the advisory committee but we are hoping that within about a week afterwards we will see an authorization if everything goes well for each of those,' Marks said.

It could come even sooner. In anticipation of an EUA, the CDC's Advisory Committee on Immunization Practices has scheduled emergency meetings for Friday and Sunday. This committee -- which is separate from FDA's advisory committee -- will recommend whether the CDC should offer the vaccine to the American public.

Once the CDC accepts that recommendation, healthcare workers may start giving people their fisrt doses of Pfizer vaccine.

The VRPBAC is scheduled to do it all over again next week, with a meeting December 17 to discuss Moderna's EUA application.

Huntsville/Redstone
Clear
55° wxIcon
Hi: 60° Lo: 37°
Feels Like: 55°
Muscle Shoals
Clear
56° wxIcon
Hi: 62° Lo: 32°
Feels Like: 56°
Huntsville/Madison
Clear
50° wxIcon
Hi: 60° Lo: 34°
Feels Like: 50°
Decatur
Clear
56° wxIcon
Hi: 61° Lo: 36°
Feels Like: 56°
Fort Payne
Clear
50° wxIcon
Hi: 62° Lo: 37°
Feels Like: 50°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Alabama Coronavirus Cases

Cases: 494421

Reported Deaths: 9991
CountyCasesDeaths
Jefferson711451374
Mobile36184735
Madison32457458
Tuscaloosa24213412
Montgomery22636517
Shelby22020214
Baldwin19790284
Lee14980154
Morgan13693251
Calhoun13307287
Etowah13192320
Marshall11269209
Houston10102261
Elmore9408185
Limestone9376134
Cullman8903181
St. Clair8839224
Lauderdale8601212
DeKalb8465175
Talladega7552164
Walker6538258
Jackson6503103
Autauga630391
Blount6106127
Colbert5993119
Coffee5254102
Dale4648107
Russell405233
Franklin399478
Covington3970106
Chilton3883100
Escambia378172
Tallapoosa3596143
Clarke343753
Chambers3421111
Dallas3412141
Pike293372
Lawrence283684
Marion283495
Winston247368
Bibb245460
Geneva240270
Marengo236557
Pickens224555
Barbour212451
Hale210668
Fayette200957
Butler197566
Henry182641
Cherokee177139
Monroe166339
Randolph163840
Washington156635
Crenshaw145254
Clay145054
Macon142343
Cleburne137841
Lamar133133
Lowndes131251
Wilcox122525
Bullock117136
Conecuh106724
Perry105827
Sumter98632
Coosa89224
Greene88232
Choctaw55123
Out of AL00
Unassigned00

Tennessee Coronavirus Cases

Cases: 776337

Reported Deaths: 11436
CountyCasesDeaths
Shelby873161492
Davidson81556869
Knox46018581
Hamilton40396462
Rutherford38385382
Williamson25282203
Sumner21383315
Montgomery17414213
Out of TN1695094
Wilson16423210
Unassigned15587125
Sullivan14346274
Blount14066181
Bradley12918139
Washington12774234
Maury12220163
Sevier12038163
Putnam10603169
Madison10102228
Robertson8962121
Hamblen8023164
Anderson7991157
Greene7294145
Tipton6948103
Coffee6320115
Dickson6228106
Gibson6188141
Cumberland6106121
Carter5974152
McMinn593191
Roane590796
Bedford5797120
Loudon569665
Jefferson5659119
Lawrence556883
Monroe533190
Warren531475
Hawkins525194
Dyer5237101
Franklin473685
Fayette466971
Obion436595
Rhea415173
Lincoln414062
Cocke399093
Cheatham391244
Marshall391156
Campbell380459
Weakley378959
Giles373896
Henderson361973
Carroll348981
Hardeman338564
White338266
Macon336573
Hardin331063
Lauderdale309242
Henry300975
Marion294144
Scott287644
Wayne287130
Overton284857
Claiborne279768
McNairy267853
DeKalb265549
Hickman265141
Haywood264860
Smith256036
Grainger243146
Trousdale239022
Morgan229738
Fentress229344
Johnson216338
Chester201748
Bledsoe200210
Crockett197247
Unicoi180547
Polk176522
Cannon175029
Union172233
Grundy168630
Lake167826
Sequatchie156027
Decatur153937
Humphreys153721
Benton151039
Lewis147025
Meigs126621
Jackson125234
Stewart123624
Clay107130
Perry103327
Houston102932
Moore94416
Van Buren79520
Pickett74623
Hancock49512

Community Events